Literature DB >> 12639194

Safety and statin therapy: reconsidering the risks and benefits.

Antonio M Gotto.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12639194     DOI: 10.1001/archinte.163.6.657

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  15 in total

1.  Monitoring drug treatment.

Authors:  Munir Pirmohamed; Robin E Ferner
Journal:  BMJ       Date:  2003-11-22

2.  Statins and monitoring of liver function tests.

Authors:  Karam Kostner; Laurence G Howes
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  Adverse effects of statins : how should cardiologists and general physicians manage them in clinical practice?

Authors:  Giuliano Tocci; Valentina Francione; Sebastiano Sciarretta; Massimo Volpe
Journal:  High Blood Press Cardiovasc Prev       Date:  2005-09

4.  Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstacles.

Authors:  Oliver Neuhaus; Olaf Stüve; Scott S Zamvil; Hans-Peter Hartung
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Simvastatin reduces VCAM-1 expression in human umbilical vein endothelial cells exposed to lipopolysaccharide.

Authors:  Johnson Chia-Shen Yang; Faye Huang; Chia-Jung Wu; Yi-Chun Chen; Tsu-Hsiang Lu; Ching-Hua Hsieh
Journal:  Inflamm Res       Date:  2012-01-15       Impact factor: 4.575

6.  Underappreciated statin-induced myopathic weakness causes disability.

Authors:  Bruce H Dobkin
Journal:  Neurorehabil Neural Repair       Date:  2005-09       Impact factor: 3.919

7.  Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.

Authors:  Anita Conforti; Lara Magro; Ugo Moretti; Stefania Scotto; Domenico Motola; Francesco Salvo; Barbara Ros; Roberto Leone
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

8.  Rosuvastatin reduced deep vein thrombosis in ApoE gene deleted mice with hyperlipidemia through non-lipid lowering effects.

Authors:  K A Patterson; X Zhang; S K Wrobleski; A E Hawley; D A Lawrence; T W Wakefield; D D Myers; J A Diaz
Journal:  Thromb Res       Date:  2012-12-29       Impact factor: 3.944

Review 9.  Secondary prevention of coronary heart disease in elderly patients following myocardial infarction: are all HMG-CoA reductase inhibitors alike?

Authors:  Bijesh P Maroo; Carl J Lavie; Richard V Milani
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

10.  Characterization of Statin-Associated Myopathy Case Reports in Thailand Using the Health Product Vigilance Center Database.

Authors:  Pornwalai Boonmuang; Surakit Nathisuwan; Nathorn Chaiyakunapruk; Wimon Suwankesawong; Pattreya Pokhagul; Nattawat Teerawattanapong; Pairin Supsongserm
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.